1.6300
24-January-25 15:45:00
15 minutes delayed
Stocks
-0.0693
-4.08%
Today's range
1.6300 - 1.7014
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 08:00:00 By Nasdaq GlobeNewswire